Trial intelligence / Profile preview

Oralgam for GI Dysfunction in Autism

NCT00110708Phase 2Unknown

Sponsor
PediaMed Pharmaceuticals
Start
Apr 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of Oralgam in Digestive tract dysfunction, sponsored by PediaMed Pharmaceuticals. Status: unknown.

02

Drugs

Oralgam
03

Conditions

Digestive tract dysfunction

Beyond the preview

Go deeper on NCT00110708.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00110708.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call